Atractylenolide I inhibits lipopolysaccharide-induced inflammatory responses via mitogen-activated protein kinase pathways in RAW264.7 cells

References

• Arenzana-Seisdedos F, Virelizier JL. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 1983;13:437–440
   PubMedGoogle Scholar
• Mongan LC, Jones T, Patrick G. Cytokine and free radical responses of alveolar macrophages in vitro to asbestos fibres. Cytokine 2000;12:1243–1247
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997;112:321S–329S
   PubMed Web of Science ®Google Scholar
• Palladino MA, Bahjat FR, Theodorakis EA, Moldawer LL. Anti-TNF-alpha therapies: the next generation. Nat Rev Drug Discov 2003;2:736–746
   PubMed Web of Science ®Google Scholar
• Ajizian SJ, English BK, Meals EA. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 1999;179:939–944
   PubMed Web of Science ®Google Scholar
• Akashi S, Shimazu R, Ogata H, et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000;164:3471–3475
   PubMed Web of Science ®Google Scholar
• Yu H, Ha T, Liu L, et al. Scavenger receptor A (SR-A) is required for LPS-induced TLR4 mediated NF-κB activation in macrophages. Biochim Biophys Acta 2012;1823:1192–1198
   PubMed Web of Science ®Google Scholar
• Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003;74:479–485
   PubMed Web of Science ®Google Scholar
• Natoli G, Chiocca S. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci Signal 2008;1:pe1
   PubMedGoogle Scholar
• Zhao Q, Shepherd EG, Manson ME, et al. The role of mitogen-activated protein kinase phosphatase-1 in the response of alveolar macrophages to lipopolysaccharide: attenuation of proinflammatory cytokine biosynthesis via feedback control of p38. J Biol Chem 2005;280:8101–8108
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 2011;41:2477–2481
   PubMed Web of Science ®Google Scholar
• Peng W, Han T, Xin WB, et al. Comparative research of chemical constituents and bioactivities between petroleum ether extracts of the aerial part and the rhizome of Atractylodes macrocephala. Med Chem Res 2011;20:146–151
   Web of Science ®Google Scholar
• Endo K, Taguchi T, Taguchi F, et al. Antiinflammatory principles of Atractylodes rhizomes. Chem Pharm Bull (Tokyo) 1979;27:2954–2958
   PubMed Web of Science ®Google Scholar
• Sin KS, Kim HP, Lee WC, Pachaly P. Pharmacological activities of the constituents of Atractylodes rhizomes. Arch Pharm Res 1989;12:236–238
   Google Scholar
• Yang HJ, Jang DJ, Hwang JT. Anti-diabetic effects of Korean red pepper via MPK and PPAR-γ activation in C2C12 myotubes. J Funct Foods 2012;4:552–558
   Web of Science ®Google Scholar
• Shapiro L, Dinarello CA. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci U S A 1995;92:12230–12234
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. The biology of cachectin/TNF-α primary mediator of the host response. Annu Rev Immunol 1989;7:625–655
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw 1996;7:93–124
   PubMed Web of Science ®Google Scholar
• Roth J, Störr B, Voigt K, Zeisberger E. Inhibition of nitric oxide synthase attenuates lipopolysaccharide-induced fever without reduction of circulating cytokines in guinea-pigs. Pflugers Arch 1998;436:858–862
   PubMed Web of Science ®Google Scholar
• Li CQ, He LC, Jin JQ. Atractylenolide I and atractylenolide III inhibit Lipopolysaccharide-induced TNF–alpha and NO production in macrophages. Phytother Res 2007;21:347–353
   PubMed Web of Science ®Google Scholar
• Wang CH, Duan HJ, He LC. Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro. Eur J Pharmacol 2009;612:143–152
   PubMed Web of Science ®Google Scholar
• Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85–94
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001;107:135–142
   PubMed Web of Science ®Google Scholar
• Caivano M. Role of MAP kinase cascades in inducing arginine transporters and nitric oxide synthetase in RAW264 macrophages. FEBS Lett 1998;429:249–253
   PubMed Web of Science ®Google Scholar
• Vanden Berghe W, Plaisance S, Boone E, et al. p38 And extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 1998;273:3285–3290
   PubMed Web of Science ®Google Scholar
• Bayon Y, Ortiz MA, Lopez-Hernandez FJ, et al. Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis. Mol Cell Biol 2003;23:1061–1074
   PubMedGoogle Scholar
• D'Acquisto F, May MJ, Ghosh S. Inhibition of nuclear factor kappa B (NF-κB): an emerging theme in anti-inflammatory therapies. Mol Interv 2002;2:22–35
   PubMedGoogle Scholar
• Shin EM, Zhou HY, Guo LY, et al. Anti-inflammatory effects of glycyrol isolated from Glycyrrhiza uralensis in LPS-stimulated RAW264.7 macrophages. Int Immunopharmacol 2008;8:1524–1532
   PubMed Web of Science ®Google Scholar
• Perera PY, Mayadas TN, Takeuchi O, et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 2001;166:574–581
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll–like receptor signalling. Nat Rev Immunol 2007;7:353–364
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Fitzgerald KA, Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 2003;24:286–290
   PubMedGoogle Scholar
• Oshikawa K, Sugiyama Y. Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. Biochem Biophys Res Commun 2003;305:649–655
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang YY, Guo L, et al. Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling. PLoS One 2013;8:e78051
   PubMed Web of Science ®Google Scholar
• Li CQ, He LC, Dong HY, Jin JQ. Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz. J Ethnopharmacol 2007;114:212–217
   PubMed Web of Science ®Google Scholar
• Li C, He L. Establishment of the model of white blood cell membrane chromatography and screening of antagonizing TLR4 receptor component from Atractylodes macrocephala Koidz. Sci China C Life Sci 2006;49:182–189
   PubMedGoogle Scholar
• Yuan BX, Hou J, He LC, Yang GD. Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane. Acta Pharmacol Sin 2005;26:113–116
   PubMed Web of Science ®Google Scholar
• Huang JM, Zhang GN, Shi Y, et al. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Sci Rep 2014;4:3840
   Google Scholar